Literature DB >> 30485537

Sensorimotor subthalamic stimulation restores risk-reward trade-off in Parkinson's disease.

Friederike Irmen1,2,3, Andreas Horn1, David Meder4, Wolf-Julian Neumann1,5, Philip Plettig1, Gerd-Helge Schneider5, Hartwig Roman Siebner4,6, Andrea A Kühn1,2,7.   

Abstract

BACKGROUND: STN-DBS effectively treats motor symptoms of advanced PD. Nonmotor cognitive symptoms, such as impaired impulse control or decision making, may either improve or worsen with DBS. A potential mediating factor of DBS-induced modulation of cognition is the electrode position within the STN with regard to functional subareas of parallel motor, cognitive, and affective basal ganglia loops. However, to date, the volume of tissue activated and weighted stimulation of STN motor versus nonmotor territories are yet to be linked to differential DBS effects on cognition.
OBJECTIVES: We aim to investigate whether STN-DBS influences risk-reward trade-off decisions and analyze its dependency on electrode placement.
METHODS: Seventeen PD patients ON and OFF STN-DBS and 17 age-matched healthy controls conducted a sequential decision-making task with escalating risk and reward. We computed the effect of STN-DBS on risk-reward trade-off decisions, localized patients' bilateral electrodes, and analyzed the predictive value of volume of tissue activated in STN motor and nonmotor territories on behavioral change.
RESULTS: We found that STN-DBS not only improves PD motor symptoms, but also normalizes overly risk-averse decision behavior in PD. Intersubject variance in electrode location could explain this behavioral change. Specifically, if STN-DBS activated preferentially STN motor territory, patients' risk-reward trade-off decisions more resembled those of healthy controls.
CONCLUSIONS: Our findings support the notion of convergence of different functional circuits within the STN and imply a positive effect of well-placed STN-DBS on nonmotor cognitive functioning in PD.
© 2018 International Parkinson and Movement Disorder Society. © 2018 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  decision making; deep brain stimulation; reward; risk-taking; subthalamic nucleus

Year:  2018        PMID: 30485537     DOI: 10.1002/mds.27576

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  7 in total

1.  Depression history modulates effects of subthalamic nucleus topography on neuropsychological outcomes of deep brain stimulation for Parkinson's disease.

Authors:  Ian H Kratter; Ahmed Jorge; Michael T Feyder; Ashley C Whiteman; Yue-Fang Chang; Luke C Henry; Jordan F Karp; R Mark Richardson
Journal:  Transl Psychiatry       Date:  2022-05-27       Impact factor: 7.989

2.  Linking brain activity during sequential gambling to impulse control in Parkinson's disease.

Authors:  Brian N Haagensen; Damian M Herz; David Meder; Kristoffer H Madsen; Annemette Løkkegaard; Hartwig R Siebner
Journal:  Neuroimage Clin       Date:  2020-06-25       Impact factor: 4.881

3.  Adaptive deep brain stimulation as advanced Parkinson's disease treatment (ADAPT study): protocol for a pseudo-randomised clinical study.

Authors:  Dan Piña-Fuentes; Martijn Beudel; Simon Little; Peter Brown; D L Marinus Oterdoom; J Marc C van Dijk
Journal:  BMJ Open       Date:  2019-06-14       Impact factor: 2.692

4.  Measuring Subthalamic Nucleus Volume of Parkinson's Patients and Evaluating Its Relationship with Clinical Scales at Pre- and Postdeep Brain Stimulation Treatment: A Magnetic Resonance Imaging Study.

Authors:  Li Lu; Kai Xu; Lin Shi; Weiqiang Dou; Kai Liu; Hong Ma; Lixiang Xie; Chao Zhang; Cailuan Lu
Journal:  Biomed Res Int       Date:  2021-02-25       Impact factor: 3.411

5.  Theta Oscillations at Subthalamic Region Predicts Hypomania State After Deep Brain Stimulation in Parkinson's Disease.

Authors:  Yi-Chieh Chen; Hau-Tieng Wu; Po-Hsun Tu; Chih-Hua Yeh; Tzu-Chi Liu; Mun-Chun Yeap; Yi-Ping Chao; Po-Lin Chen; Chin-Song Lu; Chiung-Chu Chen
Journal:  Front Hum Neurosci       Date:  2021-12-20       Impact factor: 3.169

Review 6.  Clinical neuroscience and neurotechnology: An amazing symbiosis.

Authors:  Andrea Cometa; Antonio Falasconi; Marco Biasizzo; Jacopo Carpaneto; Andreas Horn; Alberto Mazzoni; Silvestro Micera
Journal:  iScience       Date:  2022-09-16

7.  Predict initial subthalamic nucleus stimulation outcome in Parkinson's disease with brain morphology.

Authors:  Yingchuan Chen; Guanyu Zhu; Yuye Liu; Defeng Liu; Tianshuo Yuan; Xin Zhang; Yin Jiang; Tingting Du; Jianguo Zhang
Journal:  CNS Neurosci Ther       Date:  2022-01-20       Impact factor: 5.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.